Evommune, Inc. (NYSE:EVMN) Receives $45.71 Consensus Price Target from Brokerages
Shares of Evommune, Inc. (NYSE:EVMN – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating […]
21 Feb 05:46 · The Cerbat Gem